Compounding Pharmacy Market is Emerging as a Revenue Driver for Leading Players in the Market

Compounding is the science of combining and preparing personalized medicines for patients. These medications are prepared based on the practitioner’s prescription wherein, the individual ingredients are mixed together as per the suggested dosage form, and strength. The trained pharmacists are approved to personalize the medicine for the patient meeting their specific needs such as strengths, dosage forms, flavors, and exclusion of ingredients for which the patient is allergic or sensitive. However, compounded drugs are not FDA approved, indicating that FDA does not inspect the safety and the effectiveness of these drugs. This responsibility is held by the state boards of pharmacy, who verify that the state-licensed pharmacies manufacture compound drugs comply with conditions of section 503A of the FDCA. For the purpose of inspection, compounding pharmacies are segmented into sterile and non-sterile facilities.

Obtain Report Details: http://www.transparencymarketresearch.com/compounding-pharmacy-market.html

The growing patent expiries is one of the primary growth driving factor in the compounding pharmacy market. The shortage of drugs in the U.S. as reported by the U.S. FDA and also the similar shortages globally; the various advantages of compounding drugs such as the customization according to the patients’ needs contribute to the growth of the market. However, lack of efficient regulations in place in various regions, might lead to adulterated drugs being sold in the market, which might negatively impact the market.

The compounding pharmacy market can be segmented on the basis of product type, therapeutic area, distribution channel, and region. On the basis of product type, the compounding pharmacy market can be segmented into oral medications, topical medications, suppositories, and others. The oral medications can be further segmented into capsules, tablets, suspensions, lozenges, and others. The topical medications can be further segmented into creams, gels, ointments, and others. On the basis of therapeutic area, the market can be segmented into pain medications, hormone replacement therapies, dermatological applications, and others. On the basis of distribution channel, the market can be segmented into compounding pharmacies, and traditional stores. On the basis of product type, topical medications are anticipated to record significant growth in the forecast period, owing to the growing demand for dermatological applications and rising market for hormone replacement therapies. Hormone replacement therapy is anticipated to be the growing application in the forecast period, owing to their growing application in the treatment of various diseases such as cancer, and also in maintaining the hormonal levels in menopause. On the basis of distribution channel, compounding pharmacy stores which are approved by state regulatory bodies are anticipated to record robust growth in the forecast period.

Fill the form for an exclusive sample of this report: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=25310

Geographically, the market can be segmented into five regions, including North America, Latin America, Asia Pacific, Europe, and Middle East & Africa. North America was the leading region in the compounding pharmacy market. It is anticipated to be the highest revenue contributor in the forecast period. The growth can be attributed to the shortage of drugs reported by the FDA in the U.S. Europe in anticipated to be trailing next region in terms of revenue contribution to the market. Asia Pacific is anticipated to record highest CAGR growth in the forecast period. This growth can be attributed to the growing pharmaceutical awareness among people, increasing geriatric population, and expansion of infrastructural facilities, among others. The growth in Asia Pacific is expected to be driven by India, and China among other countries.

The leading players in the compounding pharmacy market include Fagron, Compounding Pharmacies, Institutional Pharmacy Solutions, B. Braun Melsungen AG Company, Cantrell Drug Company, PharMEDium Services LLC, Triangle Lorraine’s Pharmacy, and Fresenius Kabi AG., among others.

The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.

Transparency Market Research (TMR) is a U.S.-based provider of syndicated research, customized research, and consulting services. TMR’s global and regional market intelligence coverage includes industries such as pharmaceutical, chemicals and materials, technology and media, food and beverages, and consumer goods, among others. Each TMR research report provides clients with a 360-degree view of the market with statistical forecasts, competitive landscape, detailed segmentation, key trends, and strategic recommendations.

Contact us:
Transparency Market Research
90 State Street,
Suite 700,
Albany
NY - 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com/

This release was published on openPR.